Mezcla de enzimas Gateway™ LR Clonase™ II
Mezcla de enzimas Gateway™ LR Clonase™ II
Invitrogen™

Mezcla de enzimas Gateway™ LR Clonase™ II

La mezcla de enzimas Gateway™ LR Clonase™ II cataliza la recombinación in vitro entre un clon de entrada (que contieneMás información
Have Questions?
Cambiar vistabuttonViewtableView
Número de catálogoCantidad
1179102020 reacciones
11791100100 reacciones
Número de catálogo 11791020
Precio (MXN)
9,356.07
Each
Añadir al carro de la compra
Cantidad:
20 reacciones
Precio (MXN)
9,356.07
Each
Añadir al carro de la compra
La mezcla de enzimas Gateway™ LR Clonase™ II cataliza la recombinación in vitro entre un clon de entrada (que contiene un gen de interés flanqueado por sitios attL) y un vector de destino (que contiene sitios attR) para generar un clon de expresión. Gateway™ LR Clonase™ II contiene enzimas y una solución tampón en una sola mezcla para facilitar una reacción práctica de 10 microlitros en menos pasos de pipeteo.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Tampón compatibleTampón de enzimas
Tipo de productoMezcla de enzimas LR Clonase
Cantidad20 reacciones
Condiciones de envíoHielo seco
EnzimaLR Clonase
Línea de productosClonase, Gateway
Unit SizeEach
Contenido y almacenamiento
La mezcla de enzimas Gateway™ LR Clonase™ II incluye una solución de proteinasa K (2 μg/μl) y un vector de control positivo. Almacenar entre -20 °C y -80 °C. Se garantiza la estabilidad durante 6 meses si se almacena correctamente.

Preguntas frecuentes

I performed an LR reaction and got high background after transformation. Can you please offer some troubleshooting tips?

– Check whether the reaction was transformed into an E.coli strain containing the F' episome and the ccdA gene – use an E.coli strain that does not contain the F&339; episome, e.g. OmniMAX 2-T1R, TOP10.
– Deletion (full or partial) of the ccdB gene – propagate in media with 50-100 mg/mL ampicillin and 15-30 µg/mL chloramphenicol.
– Contamination from another resistant strain.
– Check whether proper amount of DNA was used in the reaction.

I performed an LR reaction and got two distinct types of colonies (large and small) after transformation. What could be the possible reasons?

– Plasmid was lost during culture due to large size or toxicity – try incubating at 30 degrees C; use Stbl2 E.coli to stabilize the plasmid.
– Deletions (full or partial) or point mutations in the ccdB gene – obtain a new Destination vector.
– Small colonies may be unreacted entry clone that co-transforms with the Expression clone – reduce the amount of Entry clone to 50 ng per 10 µL reaction; reduce the volume of sample used for transformation to 1 µL; for a Destination vector with ampicillin selection marker, increase the ampicillin concentration to 300 µg/mL.

I performed an LR reaction and got no colonies after transformation, and the recombination positive control was not successful. Can you please offer some suggestions?

– Check the competent cells with pUC19 transformation.
– Increase the amount plated.

I performed an LR reaction and got few or no colonies after transformation, whereas the transformation control gave colonies. Can you please offer some suggestions?

– Increase the incubation time up to 18 hours.
– Make sure to treat reactions with proteinase K before transformation.
– Check whether the correct antibiotic was used for selection.
– Check whether the att site sequences are correct.
– Check whether the correct Clonase enzyme was used and whether it was functional.
– Check whether the recommended amount of DNA was used in the reaction.
– Perform the positive control recombination with pENTR-Gus plasmid.
– If the Entry clone or Destination vector is too large (>10 kb), incubate the LR reaction overnight, linearize the Destination vector or the Entry clone or relax the Destination vector with topoisomerase I.

Can I create a single Entry vector for use with DEST vectors that have N-terminal tags and C-terminal tags?

No, since a stop codon would be necessary for an N-terminal tagged destination vector, whereas the presence of a stop codon would block expression of the C-terminal tag.

Citations & References (2)

Citations & References
Abstract
Development of R4 gateway binary vectors (R4pGWB) enabling high-throughput promoter swapping for plant research.
Authors:Nakagawa T, Nakamura S, Tanaka K, Kawamukai M, Suzuki T, Nakamura K, Kimura T, Ishiguro S,
Journal:Biosci Biotechnol Biochem
PubMed ID:18256458
We developed a new series of Gateway binary vectors, R4pGWBs, that are plant transformation vectors designed for one-step construction of chimeric genes between any promoter and any cDNA. The structure of R4pGWBs is almost the same as the promoterless type of improved pGWBs (ImpGWBs), except that the attR1 site is ... More
Estrogen related receptors stimulate pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression.
Authors:Zhang Y, Ma K, Sadana P, Chowdhury F, Gaillard S, Wang F, McDonnell DP, Unterman TG, Elam MB, Park EA,
Journal:J Biol Chem
PubMed ID:17079227
The pyruvate dehydrogenase complex (PDC) catalyzes the conversion of pyruvate to acetyl-CoA in mitochondria and is a key regulatory enzyme in the oxidation of glucose to acetyl-CoA. Phosphorylation of PDC by the pyruvate dehydrogenase kinases (PDK2 and PDK4) inhibits PDC activity. Expression of the PDK genes is elevated in diabetes ... More